Use of androgen receptor degrader for the treatment of spinal and bulbar muscular atrophy
CO20260008390A2Pending Publication Date: 2026-08-20ARVINAS OPERATIONS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CO20260008390
- Authority / Receiving Office
- CO · CO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-12-06
- Filing Date
- 2026-06-04
- Publication Date
- 2026-08-20
Abstract
This description refers to methods for treating or preventing spinal and bulbar muscular atrophy (SBMA), or one or more symptoms of SBMA, wherein the method comprises administering to a subject in need an effective amount of Compound A, or a pharmaceutically acceptable salt thereof.
Need to check novelty before this filing date? Find Prior Art